1,1'-{[1,4-Di(propane-1,3-diyl)hexahydropiperazine]dioxy}-bis[(11aS)-2-difluoromethylidine-7-methoxy-1,2,3,11atetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one]

ID: ALA447990

Chembl Id: CHEMBL447990

PubChem CID: 44590713

Max Phase: Preclinical

Molecular Formula: C38H42F4N6O6

Molecular Weight: 754.78

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1OCCCN1CCN(CCCOc3cc4c(cc3OC)C(=O)N3CC(=C(F)F)C[C@H]3C=N4)CC1)N=C[C@@H]1CC(=C(F)F)CN1C2=O

Standard InChI:  InChI=1S/C38H42F4N6O6/c1-51-31-15-27-29(43-19-25-13-23(35(39)40)21-47(25)37(27)49)17-33(31)53-11-3-5-45-7-9-46(10-8-45)6-4-12-54-34-18-30-28(16-32(34)52-2)38(50)48-22-24(36(41)42)14-26(48)20-44-30/h15-20,25-26H,3-14,21-22H2,1-2H3/t25-,26-/m0/s1

Standard InChI Key:  LKEXXJWCSOWFBU-UIOOFZCWSA-N

Associated Targets(non-human)

DNA (1199 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
bamHIR Type-2 restriction enzyme BamHI (13 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 754.78Molecular Weight (Monoisotopic): 754.3102AlogP: 5.72#Rotatable Bonds: 12
Polar Surface Area: 108.74Molecular Species: NEUTRALHBA: 10HBD:
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): #RO5 Violations (Lipinski): 3
CX Acidic pKa: CX Basic pKa: 7.84CX LogP: 2.53CX LogD: 1.96
Aromatic Rings: 2Heavy Atoms: 54QED Weighted: 0.20Np Likeness Score: -0.06

References

1. Kamal A, Rajender, Reddy DR, Reddy MK, Balakishan G, Shaik TB, Chourasia M, Sastry GN..  (2009)  Remarkable enhancement in the DNA-binding ability of C2-fluoro substituted pyrrolo[2,1-c][1,4]benzodiazepines and their anticancer potential.,  17  (4): [PMID:19168361] [10.1016/j.bmc.2008.12.068]

Source